Optogenetic therapeutic cell implants.
Department of Biosystems Science and Engineering, Basel, Switzerland.
David
D
Ausländer
Martin
M
Fussenegger
D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D017690:Cell Transplantation / Q000295:instrumentation / Q000379:methods*; D003924:Diabetes Mellitus, Type 2 / Q000378:metabolism / Q000628:therapy*; D052216:Glucagon-Like Peptide 1 / Q000378:metabolism*; D006801:Humans; D020007:Implants, Experimental; D008027:Light; D060847:Metabolic Engineering / Q000295:instrumentation / Q000379:methods*; D051379:Mice; D010786:Photoreceptor Cells / Q000378:metabolism*; D010789:Phototherapy / Q000295:instrumentation / Q000379:methods*; D017299:Rod Opsins / Q000378:metabolism; D015398:Signal Transduction; D058615:Synthetic Biology; D000099210:Melanopsin
D001786:Blood Glucose; D052216:Glucagon-Like Peptide 1; D017299:Rod Opsins; D000099210:Melanopsin